XM does not provide services to residents of the United States of America.

Wacker Chemie beats Q1 core profit expectations as orders pick up



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>UPDATE 2-Wacker Chemie beats Q1 core profit expectations as orders pick up</title></head><body>

Adds analyst comment in paragraph 3, details about silicon division in paragraph 6, share movement in paragraph 10

April 25 (Reuters) -German chemical company Wacker Chemie WCHG.DE reported a 39% fall in first-quarter core profit on Thursday, largely due to lower selling prices, but still beat analysts' expectations on the back of an increase in orders and cost-cutting measures.

The speciality chemicals maker reported earnings before interest, taxes, depreciation and amortisation (EBITDA) of 172 million euros ($184.2 million), beating the 150.2 million euros expected by analysts in a company-provided poll.

"I think the shares will react positively to this earnings release. EBITDA beat expectations, and silicones volumes appear to be recovering well. Cash flow performance was lacklustre, but as a whole, these are good results," Sebastian Bray from Berenberg said.

The Bavaria-based company said its first-quarter sales reached 1.5 billion euros, in-line with analysts' estimate, with the amount of incoming orders rising 8% from the previous quarter.

"Our customers have started to replenish their inventories from the recently very low levels. The demand for silicones in particular trended upward in the first quarter," CEO Christian Hartel said in a statement.

Wacker's silicones division's sales in the first quarter were up 17% compared to the previous quarter as customer demand grew. EBITDA more than doubled, due to plant utilisation rates, lower raw material prices, and positive investment income.

However, Hartel added that this could not yet be seen as a "distinct sign of a lasting turnaround."

In March, Germany's chemicals industry body VCI said it expects revenue to fall by 3.5% in 2024 and production to stagnate at a low level, citing high production costs and weak demand.

Wacker Chemie, which supplies polysilicon for roughly half the world's chips, also confirmed its earlier 2024 EBITDA forecast of 600 million and 800 million euros against 824 million in 2023, saying it expects volumes to grow this year, but selling prices to be lower.

The company's shares were seen up 1.9% in early Frankfurt trade.


($1 = 0.9340 euros)



Reporting by Antonis Pothitos and Anastasiia Kozlova in Gdansk; Editing by Kim Coghill, Varun H K and Ros Russell

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.